← Evidence map

ArticleOncoTargets and therapy2021

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV.

Serena De Matteis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 34366674